NasdaqGS - Nasdaq Real Time Price USD

C4 Therapeutics, Inc. (CCCC)

Compare
3.7000
+0.0200
+(0.54%)
As of 10:53:57 AM EST. Market Open.
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-77,808.0000
-106,838.0000
-105,939.0000
-86,965.0000
-67,249.0000
Investing Cash Flow
24,568.0000
158,349.0000
58,422.0000
-189,336.0000
-190,505.0000
Financing Cash Flow
81,637.0000
45,489.0000
1,147.0000
171,400.0000
348,932.0000
End Cash Position
76,557.0000
130,033.0000
33,033.0000
79,403.0000
184,304.0000
Income Tax Paid Supplemental Data
--
1,003.0000
--
--
143.0000
Interest Paid Supplemental Data
138.0000
990.0000
1,624.0000
1,308.0000
820.0000
Capital Expenditure
-954.0000
-1,708.0000
-5,496.0000
-1,277.0000
-650.0000
Issuance of Capital Stock
91,762.0000
57,673.0000
--
169,465.0000
340,599.0000
Issuance of Debt
--
--
--
--
11,973.0000
Repayment of Debt
-11,000.0000
-12,500.0000
--
--
--
Repurchase of Capital Stock
-125.0000
-110.0000
--
--
-194.0000
Free Cash Flow
-78,762.0000
-108,546.0000
-111,435.0000
-88,242.0000
-67,899.0000
12/31/2020 - 10/2/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers